These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 9407173)

  • 1. Application of lipid microspheres containing prostaglandin E1 ointment to peripheral ischemic ulcers.
    Sakakibara Y; Jikuya T; Mitsui T
    Dermatology; 1997; 195(3):253-7. PubMed ID: 9407173
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A multicenter double blind controlled study of lipo-PGE1, PGE1 incorporated in lipid microspheres, in peripheral vascular disease secondary to connective tissue disorders.
    Mizushima Y; Shiokawa Y; Homma M; Kashiwazaki S; Ichikawa Y; Hashimoto H; Sakuma A
    J Rheumatol; 1987 Feb; 14(1):97-101. PubMed ID: 3553591
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The transepidermal absorption of prostaglandin E1 as a topical ointment: an experimental study of application over a rat skin flap.
    Nakanishi Y; Nakajima T; Yoshimura Y; Okamoto Y; Yamada T
    Ann Plast Surg; 1998 Jan; 40(1):44-7. PubMed ID: 9464695
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipo-PGE1, a new lipid-encapsulated preparation of prostaglandin E1: placebo-and prostaglandin E1-controlled multicenter trials in patients with diabetic neuropathy and leg ulcers.
    Toyota T; Hirata Y; Ikeda Y; Matsuoka K; Sakuma A; Mizushima Y
    Prostaglandins; 1993 Nov; 46(5):453-68. PubMed ID: 8278621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of lipo-prostaglandin E1 on pulmonary hemodynamics and clinical outcomes in patients with pulmonary arterial hypertension.
    Shen J; He B; Wang B
    Chest; 2005 Aug; 128(2):714-9. PubMed ID: 16100159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostaglandin E1 incorporated in lipid microspheres in the treatment of peripheral vascular diseases and diabetic neuropathy.
    Hoshi K; Mizushima Y; Kiyokawa S; Yanagawa A
    Drugs Exp Clin Res; 1986; 12(8):681-5. PubMed ID: 3757764
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of refractory ischemic skin ulcers in patients with Raynaud's phenomenon with PGE1 infusions.
    Langevitz P; Buskila D; Lee P; Urowitz MB
    J Rheumatol; 1989 Nov; 16(11):1433-5. PubMed ID: 2600942
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Combined therapy with prostaglandin E1 ointment and lumbar sympathetic ganglion block on intractable skin ulcers accompanied by Bürger's disease].
    Shirakawa J; Horikawa Y; Yaku H; Takeshi M; Obara H
    Masui; 1992 Jun; 41(6):1000-3. PubMed ID: 1613942
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beneficial effects of intravenous administration of lipo-prostaglandin E1 on the ischemic gastric tube in pigs.
    Tobari S; Ikeda Y; Takami H
    J Surg Res; 2005 Nov; 129(1):79-84. PubMed ID: 16087193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vasodilating effect and tissue accumulation of prostaglandin E1 incorporated in lipid microspheres on the rat ductus arteriosus.
    Chino Y; Minagawa T; Kohno Y; Fukushima K; Momma K
    Jpn J Pharmacol; 1999 Sep; 81(1):107-14. PubMed ID: 10580378
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipo-PGE1, prostaglandin E1 incorporated in lipid microspheres, protects injury of the liver caused by warm ischemia reperfusion.
    Egashira T; Kim YI; Takayama F; Kudo Y; Yamanaka Y
    Free Radic Biol Med; 1996; 21(3):353-6. PubMed ID: 8855446
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treatment of postherpetic neuralgia by topical application of prostaglandin E1-vaseline mixture--a single blind controlled clinical trial].
    Tamakawa S; Tsujimoto J; Iharada A; Ogawa H
    Masui; 1999 Mar; 48(3):292-4. PubMed ID: 10214018
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostaglandin E1 in lipid microspheres ameliorates diabetic peripheral neuropathy: clinical usefulness of Semmes-Weinstein monofilaments for evaluating diabetic sensory abnormality.
    Akahori H; Takamura T; Hayakawa T; Ando H; Yamashita H; Kobayashi K
    Diabetes Res Clin Pract; 2004 Jun; 64(3):153-9. PubMed ID: 15126001
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liposome encapsulated prostaglandin E1 in erectile dysfunction: correlation between in vitro delivery through foreskin and efficacy in patients.
    Foldvari M; Oguejiofor C; Afridi S; Kudel T; Wilson T
    Urology; 1998 Nov; 52(5):838-43. PubMed ID: 9801110
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of the effect of Lipo PGE1 and other related compounds on experimental peripheral arterial occlusive disease in rats.
    Goto J; Araki H; Otomo S; Aihara H
    Drugs Exp Clin Res; 1986; 12(11):917-21. PubMed ID: 3816509
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of established collagen induced arthritis with prostaglandin E1 incorporated in lipid microspheres.
    Moriuchi-Murakami E; Yamada H; Ishii O; Kikukawa T; Igarashi R
    J Rheumatol; 2000 Oct; 27(10):2389-96. PubMed ID: 11036835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical efficacy of different doses of lipo-prostaglandin E1 in the treatment of painful diabetic peripheral neuropathy.
    Hong L; Zhang J; Shen J
    J Diabetes Complications; 2015; 29(8):1283-6. PubMed ID: 26355026
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protective effect of lipid microspheres 1 on myocardial injury following elective percutaneous coronary intervention in patients with angina pectoris: a pilot study.
    Chu-fan L; Xing W; Xun H; Gui-fu W; Cheng-heng H; Zhi-min D
    J Cardiovasc Med (Hagerstown); 2011 Nov; 12(11):790-4. PubMed ID: 21934521
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improved transdermal delivery of prostaglandin E1 through hairless mouse skin: combined use of carboxymethyl-ethyl-beta-cyclodextrin and penetration enhancers.
    Uekama K; Adachi H; Irie T; Yano T; Saita M; Noda K
    J Pharm Pharmacol; 1992 Feb; 44(2):119-21. PubMed ID: 1352811
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of complications of peripheral obstructive arterial disease with prostaglandin E1.
    Killion DD; Ambrus JL
    Angiology; 1987 Jul; 38(7):507-13. PubMed ID: 3619123
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.